SNAP25-induced MYC Upregulation Promotes High-grade Neuroendocrine Lung Carcinoma Progression

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Oct 21

PMID 39430761

Authors

Zhiqiang Chen

Shujing Wang

Jingrui Wang

Ying Wang

Xiangjun Qi

Bo An

Lingling Sun

Lizhu Lin

Affiliations

Soon will be listed here.

Abstract

Background: This study investigated the expression and role of Synaptosome associated protein 25 (SNAP25) in high-grade neuroendocrine carcinoma (HGNEC).

Methods: We used differentially expressed analysis and weighted gene co-expression network analysis (WGCNA) to identify key genes and modules in HGNEC. KEGG and GO analyses helped understand these genes' roles, and ROC curves assessed their diagnostic value. We also studied SNAP25's relation to immune infiltration and confirmed findings with and vivo experiments and datasets.

Results: WGCNA identified 595 key genes related to pathways like MAPK signaling, GABAergic synapse, and cancer-related transcriptional misregulation. Top genes included SNAP25, MYC, NRXN1, GAD2, and SYT1. SNAP25 was notably associated with M2 macrophage infiltration. Dataset GSE40275 confirmed SNAP25's high expression and poor prognosis in HGNEC. qRT-PCR and WB analyses showed increased SNAP25 and c-MYC levels in HGNEC, promoting MEK/ERK pathway activity. Reducing SNAP25 decreased H1299 cell proliferation, migration, invasion, and levels of c-MYC, MEK, and ERK. Finally, experiments further confirmed that SNAP25 knockout can inhibit tumor growth.

Conclusion: SNAP25 regulates c-MYC activation by stimulating the MEK/ERK pathway, ultimately influencing the development of HGNEC.

References

Gao F, Li X, Xu K, Wang R, Guan X . c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment. Cell Commun Signal. 2023; 21(1):28. PMC: 9887805. DOI: 10.1186/s12964-023-01043-1. View

Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y . Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol. 2005; 24(1):70-6. DOI: 10.1200/JCO.2005.04.1202. View

Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha D . Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. Proc Natl Acad Sci U S A. 2015; 112(30):E4055-64. PMC: 4522819. DOI: 10.1073/pnas.1501967112. View

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

Fernandez-Cuesta L, Sexton-Oates A, Bayat L, Foll M, Lau S, Leal T . Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms. Am Soc Clin Oncol Educ Book. 2023; 43:e390794. DOI: 10.1200/EDBK_390794. View

Cao Q, Dong Z, Liu S, An G, Yan B, Lei L . Construction of a metastasis-associated ceRNA network reveals a prognostic signature in lung cancer. Cancer Cell Int. 2020; 20:208. PMC: 7271455. DOI: 10.1186/s12935-020-01295-8. View

Hayashi S, Hoerder-Suabedissen A, Kiyokage E, MacLachlan C, Toida K, Knott G . Maturation of Complex Synaptic Connections of Layer 5 Cortical Axons in the Posterior Thalamic Nucleus Requires SNAP25. Cereb Cortex. 2020; 31(5):2625-2638. PMC: 8023812. DOI: 10.1093/cercor/bhaa379. View

Manca P, Mameli O, Caria M, Torrejon-Escribano B, Blasi J . Distribution of SNAP25, VAMP1 and VAMP2 in mature and developing deep cerebellar nuclei after estrogen administration. Neuroscience. 2014; 266:102-15. DOI: 10.1016/j.neuroscience.2014.02.008. View

Wang W, Gao W, Zhang L, Xia Z, Zhao B . SNAP25 ameliorates postoperative cognitive dysfunction by facilitating PINK1-dependent mitophagy and impeding caspase-3/GSDME-dependent pyroptosis. Exp Neurol. 2023; 367:114463. DOI: 10.1016/j.expneurol.2023.114463. View

10.

Chen P, Wang W, Wong S, Li J, Wu Q, Zhang S . RUNDC3A regulates SNAP25-mediated chemotherapy resistance by binding AKT in gastric neuroendocrine carcinoma (GNEC). Cell Death Discov. 2022; 8(1):296. PMC: 9233710. DOI: 10.1038/s41420-022-01084-4. View

11.

Bi C, Zhang X, Chen Y, Dong Y, Shi Y, Lei Y . MAGT1 is required for HeLa cell proliferation through regulating p21 expression, S-phase progress, and ERK/p38 MAPK MYC axis. Cell Cycle. 2021; 20(21):2233-2247. PMC: 8794507. DOI: 10.1080/15384101.2021.1974792. View

12.

Travis W, Brambilla E, Nicholson A, Yatabe Y, Austin J, Beasley M . The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015; 10(9):1243-1260. DOI: 10.1097/JTO.0000000000000630. View

13.

Deng K, Guo X, Wang H, Xia J . The lncRNA-MYC regulatory network in cancer. Tumour Biol. 2014; 35(10):9497-503. DOI: 10.1007/s13277-014-2511-y. View

14.

Yoon T, Munson M . SNARE complex assembly and disassembly. Curr Biol. 2018; 28(8):R397-R401. DOI: 10.1016/j.cub.2018.01.005. View

15.

Minami K, Jimbo N, Tanaka Y, Ogawa H, Hokka D, Nishio W . Insulinoma-associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma. J Surg Oncol. 2020; 122(2):243-253. DOI: 10.1002/jso.25960. View

16.

Sun T, Zhao L, Van Hummelen P, Martin B, Hornbacker K, Lee H . Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites. Endocr Relat Cancer. 2022; 29(12):665-679. PMC: 10043760. DOI: 10.1530/ERC-22-0015. View

17.

Li J, Zhang C, Yuan X, Ren Z, Yu Z . Correlations between stemness indices for hepatocellular carcinoma, clinical characteristics, and prognosis. Am J Transl Res. 2020; 12(9):5496-5510. PMC: 7540154. View

18.

Morise M, Hishida T, Takahashi A, Yoshida J, Ohe Y, Nagai K . Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung. J Cancer Res Clin Oncol. 2015; 141(12):2121-30. DOI: 10.1007/s00432-015-1985-3. View

19.

Fatma H, Maurya S, Siddique H . Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance. Semin Cancer Biol. 2020; 83:166-176. DOI: 10.1016/j.semcancer.2020.11.008. View

20.

Saeed H, Leibowitz B, Zhang L, Yu J . Targeting Myc-driven stress addiction in colorectal cancer. Drug Resist Updat. 2023; 69:100963. PMC: 10330748. DOI: 10.1016/j.drup.2023.100963. View